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Summary
Background.— Early reperfusion therapy has proven beneﬁt in reducing mortality in patients
with ST-segment elevation myocardial infarction (STEMI). Expert guideline committees have
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myocardial infarction
Guidelines;
Reperfusion therapy
deﬁned recommendations to improve the management of patients with STEMI and decrease
their mortality rates.
Aims.— To identify predictors of compliance with American College of Cardiology/American
Heart Association guidelines for reperfusion therapy in STEMI and to determine the prognostic
impact of compliance.
Methods.— ESTIM Midi-Pyrénées was a multidisciplinary, prospective registry in patients with
STEMI, conducted between June 2001 and June 2003 in French hospitals. Data were analysed
from 1277 patients managed by emergency physicians in the prehospital system or emergency
room and/or cardiologists in interventional or non-interventional cardiology departments.
Results.— A revascularization strategy was performed in 89.4% of patients; treatment complied
with the guidelines in 61.1% of patients. After multivariable analysis, factors associated with
compliance were age less or equal than 75 years (odds ratio [OR] 1.56, 95% conﬁdence interval
[CI] 1.18—2.08), symptom onset during the day (OR 1.43, 95% CI 1.12—1.82), typical electro-
cardiographic symptoms of STEMI (OR 3.2, 95% CI 2.19—4.5), and initial medical contact. After
adjustment for confounders, 1-month mortality was signiﬁcantly lower in patients managed
according to guideline recommendations (OR 0.60, 95% CI 0.40—0.92).
Conclusion.— A number of factors can be used to identify STEMI patients who are less likely to be
managed according to guidelines. Training focused on these factors should improve management
and clinical outcomes of STEMI.
© 2009 Published by Elsevier Masson SAS.
MOTS CLÉS
Infarctus avec sus
décalage du segment
ST ;
Recommandations ;
Traitement de
reperfusion
Résumé
Contexte.— La mise en œuvre d’une recanalisation précoce réduit la mortalité des infarctus
du myocarde avec élévation du segment ST (IDMST+). Des recommandations sont proposées par
les sociétés savantes pour améliorer la prise en charge et diminuer la mortalité des patients
avec un IDMST+.
Objectifs.— Identiﬁer les facteurs prédictifs de suivi des recommandations de l’American Heart
Association et l’American College of Cardiology pour la reperfusion des IDMST+ et évaluer
l’impact sur le pronostic.
Méthodes.— ESTIM Midi-Pyrénées est un registre prospectif, multidisciplinaire d’IDMST+ conduit
entre juin 2001 et juin 2003 dans les hôpitaux franc¸ais. Ont été analysés 1277 patients pris en
charge par les urgentistes préhospitaliers ou des urgences et les cardiologues non intervention-
nels ou interventionnels.
Résultats.— Une stratégie de revascularisation a été mise en œuvre pour 89 % des patients, en
accord avec les recommandations pour 61,1 % des patients. Après une analyse multivariée, les
facteurs associés avec le suivi des recommandations sont l’âge inférieur à 75 ans (odds ratio [OR]
1,56, intervalle de conﬁance de 95% [IC95%]1,18—2,08), une symptomatologie diurne (OR 1,43,
IC95% 1,12—1,82), un électrocardiogramme typique (OR 3,2, 95 % CI 2,19—4,5), et le premier
contact médical. Après ajustement, la mortalité à un mois est signiﬁcativement plus basse chez
les patients pris en charge en accord avec les recommandations (OR 0,60, 95 % CI 0,40—0,92).
Conclusion.— Des facteurs de mauvais suivi de recommandations peuvent être identiﬁés chez
les patients présentant un IDMST+. La formation et la collaboration entre médecins urgentistes
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bbreviations
CC/AHA American College of Cardiology/American Heart
Association
I conﬁdence interval
ICU cardiac intensive care unit
RF case report form
CG electrocardiogram
R emergency room
STIM Évaluation des stratégies thérapeutiques dans
l’infarctus du myocarde
ICU mobile intensive care unit
R odds ratio
E
m
s
a
orer la prise en charge et l’évolution clinique.
n SAS.
CI percutaneous coronary intervention
AMU Système d’aide médicale d’urgence
.D. standard deviation
TEMI ST-segment elevation myocardial infarction
ackgroundarly reperfusion therapy has proven beneﬁt in reducing
ortality in patients with STEMI. The success of reperfusion
trategies involving either primary PCI or thrombolytic ther-
py has been demonstrated in many clinical trials [1]. Based
n analyses of data from randomized trials, expert guideline
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◦ should receive thrombolytic therapy if the door-to-
balloon time was greater than 90minutes.
• Patients at risk of bleeding from thrombolytic therapy
should have a primary PCI.Determinants and prognostic impact of compliance with STE
committees have deﬁned recommendations to improve the
management of patients with STEMI and decrease their mor-
tality rates [2]. Recommendations for reperfusion therapy
in acute myocardial infarction have been proposed by the
ACC/AHA, and were updated in 1999 [3]. These guidelines
provide recommendations on the optimal type of reper-
fusion therapy in terms of delay from symptom onset to
initial treatment as well as access to interventional facili-
ties. Nevertheless, gaps exist between these guidelines and
current clinical practice [4]. Factors associated with non-
compliance with guidelines, especially those for reperfusion
therapy, are not fully understood and require investigation
in registries that reﬂect ‘‘real life’’ practice [5].
The ESTIM Midi-Pyrénées registry was conducted over a 2-
year period (2001 to 2003) to monitor reperfusion strategies
used in patients presenting with STEMI. This registry applies
to a large area of France [6].
The aims of this study were to measure the rate of
compliance with these guidelines and to identify key fac-
tors linked to compliance. We also investigated whether
compliance with guidelines inﬂuences a patient’s short-term
prognosis.
Methods
Study design and setting
The ESTIM Midi-Pyrénées registry was a multicentre,
prospective, longitudinal, multidisciplinary study carried
out between June 2001 and June 2003 [6]. The study was
run by cardiologists and emergency physicians from public
and private hospitals in the Midi-Pyrénées area. This is the
largest region in France, encompassing both urban and rural
areas, and has a low density of inhabitants (2.5million).
Patients with STEMI may be managed by emergency
physicians either prehospital or in ER, and by cardiolo-
gists in CICU with or without catheterization laboratories.
In France, a prehospital medical system was established to
identify patients presenting with acute coronary syndromes.
Emergency physicians from the emergency medical system
(SAMU) analyse urgent calls and dispatch a MICU with a
physician on board if a diagnosis of STEMI is suspected. If
the on-board emergency physician conﬁrms the diagnosis of
STEMI, then treatment is begun immediately and the patient
is transferred to an ER or directly to a CICU with or without
a catheterization laboratory. Protocols of care were consis-
tent with the ACC/AHA guidelines (1999 update [3]) between
2001 and 2003.
The Midi-Pyrénées area includes one university hospital,
eight SAMU, 26 MICU, 37 ER, and 22 CICU of which eight
have interventional facilities. Among the eight administra-
tive units of the Midi-Pyrénées area, the ‘‘Haute-Garonne’’
department represents 40% of the population and has 70%
of the catheterization laboratories.
Selection of participantsAll patients treated for STEMI evolving within 24 hours of
symptom onset were included prospectively in the study
by their treating physicians, irrespective of whether they
were managed prehospital in a MICU, in an emergency
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epartment, or in a CICU with or without interventional
acilities. Information about the study was provided to all
atients.
To be eligible for inclusion, patients had to be aged above
r equal to 18 years and present with chest pain of more
han 20minutes duration and with ST-segment elevation on
12-lead ECG, deﬁned as greater than 0.1mV in at least
wo peripheral leads or greater than 0.2mV in at least two
recordial leads or presumed new left bundle-branch block.
ata collection and processing
emographic, clinical and electrocardiographic data were
ollected prospectively by the treating physician and
eported on a CRF. Information about the time from symp-
om onset to initial medical management and reperfusion
herapy, types of initial management and reperfusion ther-
py, and contraindications to thrombolytic therapy or PCI
ere also collected. After 1 month, either patients or their
eneral practitioners were followed up by telephone by a
esearch assistant to collect information about major car-
iac events occurring during the ﬁrst month of follow-up.
ata were entered into the database after checks on patient
ligibility and review of CRF completeness and clinical valid-
ty.
Patients were categorized according to whether their
anagement complied with the practice guidelines from the
CC/AHA that applied at the time the study was conducted
3]. Compliance was based on the following management
lgorithm and is illustrated in Fig. 1.
All patients should receive reperfusion therapy.
Patients treated greater than 12 hours after symptom
onset should undergo primary PCI (except those judged
to be unsuitable).
Patients treated within 12 hours of symptom onset:
◦ should have a primary PCI if door-to-balloon time was
equal or less than 90minutes,igure 1. American College of Cardiology/American Heart Asso-
iation guidelines (1999 update [3]) for the management of patients
ith acute myocardial infarction. PCI: percutaneous coronary inter-
ention; STEMI: ST-segment elevation myocardial infarction.
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Patients for whom thrombolysis and PCI were contraindi-
cated were considered to have been managed according
to guideline recommendations.
Time reported on the CRF was used to calculate door-to-
alloon time for patients who underwent catheterization.
or other patients, the study physician retrospectively
stimated the time between the initial medical manage-
ent and arrival at the nearest catheterization laboratory
s less than or more than 90minutes using time-to-door to
ime-to-PCI-capable hospital.
Patients were divided into groups according to their geo-
raphic location: Haute-Garonne, an area with high-volume
atheterization laboratories, and outside Haute-Garonne,
hich included low-volume catheterization laboratories and
ther non-interventional cardiology departments. In Haute-
aronne, patients were located close to a catheterization
aboratory and PCI could be performed easily.
Table 1 Baseline characteristics (n = 1277).
n (%) unless
otherwise stated
Male sex 1006 (78.8)
Age in years, mean± S.D. 63.7± 1.4
≤ 75 years 943 (74)
Site of STEMI
Anterior 493 (38.6)
Lateral 138 (10.8)
Inferior 560 (43.9)
Typical STEMI 1114 (87.2)
First medical contact
MICU 665 (52.1)
Emergency room 364 (28.5)
CICU without Cath lab 121 (9.5)
CICU with Cath lab 127 (9.9)
Location in Haute-Garonne 613 (48)
Time of symptom onset
(08.00 to 20.00 h)
736 (57.4)
Period of initial management
(08.00 to 20.00 h)
847 (66.3)
Onset of symptoms, min,
median (25th to 75th
percentile)
130 (66—300)
Door-to-reperfusion therapy,
min, median (25th to 75th
percentile)
170 (110—314)
Reperfusion strategy 1141 (89.4)
Primary PCI 477 (37.3)
Prehospital thrombolysis 322 (25.2)
In-hospital thrombolysis 342 (26.8)
Any reperfusion therapy 136 (10.7)
Death at 1 month 110 (8.6)
Compliance with guidelines 780 (61.1)
Cath lab: catheterization laboratory; CICU: cardiac intensive
care unit; MICU: mobile intensive care unit; PCI: percuta-
neous coronary intervention; S.D.: standard deviation; STEMI:
ST-segment elevation myocardial infarction.
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Patients with an anterior, lateral or inferior ST elevation
n the ECG were regarded as having a typical STEMI. Those
ith left bundle-branch block or ECG abnormalities on the
2-lead ECG suggesting a myocardial infarction in a right and
osterior location conﬁrmed by a 17-lead ECG were regarded
s having an atypical STEMI.
rimary data analysis
tatistical analyses were conducted using the STATA 9® soft-
are. Comparative analyses were made using Pearson’s 2
est and Fisher’s exact test for percentages, and Student’s
-test or the Mann-Whitney test for means. Differences were
onsidered signiﬁcant if p < 0.05. Delays were expressed as
edians with interquartile ranges.
Univariate and multivariable analyses were performed to
dentify factors predictive of compliance with guidelines.
ariables with a p-value < 0.20 in the univariate analysis
ere included in a stepwise, multivariable logistic regres-
ion analysis. OR were reported with 95% CI. Since the
ecision to provide reperfusion therapy was strongly linked
o compliance with guidelines, the variable ‘‘reperfusion
herapy’’ could not be considered as a confounding fac-
or and was not therefore introduced into the multivariable
nalysis.
esults
haracteristics of study subjects
total of 1650 patients were enrolled in the study between
une 2001 and June 2003. Of these, 373 were excluded
or the following reasons: missing data on inclusion criteria
ECG, time of symptom onset) (n = 165); no STEMI on the ECG
n = 114); no cardiac activity at initial management (n = 29);
nd time from symptom onset to initial management greater
han 24 hours (n = 65). The study population therefore com-
rised 1277 patients. Baseline characteristics of the study
opulation are given in Table 1. The distribution of patients
ho received reperfusion therapy in accordance with the
CC/AHA guidelines is shown in Fig. 2. Most patients (90.8%)
resented within 12 hours of symptom onset and the overall
ate of compliance with guidelines was 61.1%. Thrombolytic
herapy was given 2.3 times more often than angioplasty in
espect of the recommendations (95% CI 1.74—2.9).
redictors of compliance with ACC/AHA
uidelines
nivariate factors associated with compliance to guidelines
re shown in Table 2. Independent predictors of compli-
nce were age, time of symptom onset, type of STEMI, and
rst medical contact (Table 3). Guideline recommendations
ere followed less frequently for elderly patients (54.2%)
han younger patients (63.2%) (OR 0.68, 95% CI 0.53—0.88),
nd for patients presenting between 20.00 and 08.00 hours
57.7%) than during the daytime (63.3%). Guidelines were
ollowed more frequently for patients with typical STEMI
n ECG (64.5%) vs atypical symptoms (38.0%; OR 2.95, CI
.09—4.17).
Determinants and prognostic impact of compliance with STEMI guidelines 391
Figure 2. Distribution of patients for reperfusion strategy in accordance with American College of Cardiology/American Heart Association
guidelines (1999 update [3]). Compliance with guidelines is indicated in grey. PCI: percutaneous coronary intervention; STEMI: ST-segment
elevation myocardial infarction.
Table 2 Predictors of compliance with guidelines (univariate analysis).
Variable n (%) Odds ratio 95% conﬁdence interval p-value
Sex
Women 156 (57.6) Reference —
Men 624 (62.0) 1.20 0.92—1.58 0.18
Age (years)
≤ 75 599 (63.5) Reference —
> 75 180 (54.2) 0.68 0.53—0.88 0.003
Period of initial management (h)
08.00 to 20.00 536 (63.3) Reference —
20.00 to 08.00 244 (56.7) 0.76 0.60—0.96 0.02
Time of symptom onset (h)
08.00 to 20.00 480 (65.2) Reference —
20.00 to 08.00 300 (55.5) 0.66 0.53—0.83 < 0.0001
Location
Outside Haute-Garonne 476 (71.7) Reference —
Haute-Garonne 304 (49.6) 0.39 0.31—0.49 < 0.0001
Type of STEMI
Atypical 62 (38.0) Reference —
Typical 718 (64.5) 2.95 2.09—4.17 < 0.0001
First medical contact
MICU 275 (57.7) Reference —
Emergency room 313 (91.5) 1.04 0.80—1.35
CICU without Cath lab CICU with Cath lab 74 (61.2) 1.04 0.70—1.55 0.6684(66.1)
Cath lab: catheterization laboratory; CICU: cardiac intensive care unit
myocardial infarction.1.29 0.87—1.93
; MICU: mobile intensive care unit; STEMI: ST-segment elevation
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Table 3 Independent predictors of compliance with guidelines.
Variable Implementation of guidelines n (%) Odds ratio 95% conﬁdence interval p-value
Sex
Women 156 (57.6) Reference —
Men 624 (62.0) 1.03 0.76-1.39 0.87
Age (years)
> 75 180 (54.2) Reference —
≤ 75 599 (63.5) 1.56 1.18—2.08 0.002
Time of symptom onset (h)
20.00 to 08.00 300 (55.5) Reference —
08.00 to 20.00 480 (65.2) 1.43 1.12—1.82 0.004
Type of STEMI
Atypical 62 (38.0) Reference —
Typical 718 (64.5) 3.20 2.19—4.5 < 0.0001
First medical contact
Outside Haute-Garonne 476 (71.7)
MICU 229 (77.6) Reference —
Emergency room 159 (70.0) 0.64 0.42—0.95 0.03
CICU without Cath lab 61 (59.2) 0.45 0.27—0.74 0.002
CICU with Cath lab 27 (69.2) 0.56 0.26—1.18 0.13
In Haute-Garonne 304 (49.6)
MICU 171 (46.2) Reference —
Emergency room 63 (45.9) 1.08 0.72—1.61 0.71
CICU without Cath lab 13 (72.2) 3.47 1.16—10.31 0.026
CICU with Cath lab 84 (67.8) 2.53 1.53—4.18 < 0.0001
Cath lab: catheterization laboratory; CICU: cardiac intensive care unit; MICU: mobile intensive care unit; STEMI: ST-segment elevation
c
b
G
a
t
ﬁ
t
c
c
t
f
M
O
3
C
M
z
w
C
m
A
f
o
a
a
t
a
f
t
e
y
p
t
1
w
D
T
o
u
t
s
s
p
smyocardial infarction.
The variable ‘‘location’’ was a very strong predictor of
ompliance with guidelines in univariate analysis (Table 2),
ut initial management differed between patients in Haute-
aronne (with high-volume catheterization laboratories)
nd outside Haute-Garonne (with low-volume catheteriza-
ion laboratories and non-interventional cardiac units). This
nding was conﬁrmed by a statistically signiﬁcant interac-
ion between the variables ‘‘location’’ and ‘‘ﬁrst medical
ontact’’. In Haute-Garonne, physicians in CICU without
atheterization laboratories followed the guidelines 3.5
imes more frequently and those in CICU with interventional
acilities and 2.5 times more frequently than physicians in
ICU, whereas the rate of compliance in ERs did not differ.
utside Haute-Garonne, recommendations were followed
6% less frequently in the ER and 55% less frequently in
ICU without a catheterization laboratory compared with in
ICU, but there was no difference in CICU with a catheteri-
ation laboratory. Gender was not predictive of compliance
ith guidelines.
ompliance as a predictor of 1-month
ortalitymong the 1277 patients in the study, 1253 (98%) were
ollowed-up for 1 month post-discharge; 110 (8.6%) deaths
ccurred during the study. Compliance with guidelines was
ssociated with short-term prognosis (Table 4). In univariate
nalysis, mortality was associated with sex, age, location,
S
[
t
i
wype of STEMI, use of reperfusion therapy, and compli-
nce with guidelines. After multivariable analysis adjusting
or potential confounders, men (6.5%) were less likely
han women (17.1%) to die (OR 0.47, 95% CI 0.30—0.72),
lderly (19.4%) patients were more likely to die than
ounger patients (4.9%) (OR 3.96, 95% CI 2.59—4.80), and
atients with typical STEMI (9.4%) were more likely to die
han patients with atypical STEMI (4.4%) (OR 3.35, 95% CI
.48—7.58). Patients treated according to the guidelines
ere 39% less likely to die (OR 0.61, 95% CI 0.40—0.92).
iscussion
o our knowledge, no previous study has assessed predictors
f compliance with practice guidelines, especially for the
se of reperfusion therapy. We also took into consideration
he type of initial management, including the prehospital
etting and the time of ﬁrst medical management after
ymptom onset. This observational study reﬂects real-life
ractice in our area.
Studies and registries have focused mainly on reperfu-
ion strategies or use of recommended drugs in patients with
T-elevation or non-ST elevation acute coronary syndromes
4,5]. In the present study, the ACC/AHA recommenda-
ions for reperfusion therapy in STEMI were implemented
n almost two-thirds of patients. In another French registry,
hich examined the use of recommended drugs and reper-
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Table 4 Factors associated with mortality at 1 month (univariate and multivariable analysis).
Univariate analysis Multivariable analysis
Variable Death n (%) OR 95% CI p-value OR 95% CI p-value
Sex
Women 46 (17.1) Reference — — Reference — —
Men 64 (6.5) 0.34 0.22—0.51 < 0.0001 0.47 0.30—0.72 0.001
Age (years)
≤ 75 46 (4.9) Reference — — Reference — —
>75 64 (19.4) 4.58 3.02-6.92 < 0.0001 3.96 2.59—4.80 < 0.0001
Period of initial management (h)
08.00 to 20.00 72 (8.6) Reference — — — — —
20.00 to 08.00 38 (9.1) 1.06 0.70—1.59 0.80 — — —
Time of symptoms onset (h)
08.00 to 20.00 70 (9.7) Reference — — Reference — —
20.00 to 08.00 40 (7.5) 0.76 0.50—1.13 0.18 0.72 0.47—1.17 0.13
Geographic location
Outside Haute-Garonne 70 (10.7) Reference —
Haute-Garonne 40 (6.7) 0.60 0.40—0.90 0.01 — — —
Type of STEMI
Atypical 7 (4.4) Reference — — Reference — —
Typical 103 (9.4) 2.24 1.02—4.91 0.04 3.35 1.48—7.58 0.004
First medical contact
MICU 57 (8.7) Reference — 0.15 — — —
Emergency room 27 (7.6) 0.87 0.54—1.39 — — —
CICU without cath lab 17 (14.2) 1.73 0.97—3.10 — — —
CICU with Cath lab 9 (7.4) 0.84 0.40—1.74 — — —
Reperfusion therapy
No 41 (30.4) Reference — — — — —
Yes 69 (6.2) 0.15 0.10—0.24 < 0.0001 — — —
Reperfusion strategy
Primary PCI 26 (5.6) Reference — — — — —
Thrombolysis 43 (6.6) 1.19 0.72—1.97 0.49
Compliance with guidelines
No 54 (11.1) Reference — — Reference — —
Yes 56 (7.3) 0.63 0.43—0.93 0.02 0.61 0.40—0.92 0.02
Cath lab: catheterization laboratory; CICU: cardiac intensive care units; MICU: mobile intensive care unit; PCI: percutaneous coronary intervention; STEMI: ST-segment elevation myocardial
infarction.
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usion therapy, the compliance index — the ratio of actual
reatment to theoretical treatment — in the STEMI group
as 0.76 [5].
Among the factors analysed, age was predictive of
ompliance with guidelines. Elderly patients beneﬁted from
either guideline implementation nor, in most cases, reper-
usion therapy. Failure to give reperfusion therapy in elderly
atients could be related to their frequent atypical clinical
resentation without chest pain [7—9], to their high rate of
omorbid conditions such as diabetes and high blood pres-
ure, and to their higher risk clinical presentation including
ardiogenic shock and Killip class III [10,11]. Data regarding
he efﬁcacy of reperfusion therapy in elderly patients are
nconsistent: some studies show that thrombolytic therapy
an reduce the rate of 1-month mortality in elderly patients,
ven in those at increased risk of bleeding [12], while others
ave shown that thrombolytic therapy has a negative impact
n prognosis in this population [13,14]. Guidelines suggest
hrombolytic therapy for elderly patients as a class IIa rec-
mmendation [6]. Elderly patients beneﬁt from primary PCI
fter taking into account their clinical features. Horvilleur et
l., in a French registry of octogenarians, showed a decrease
n mortality and a corresponding increase in the rate of PCI
15].
Atypical STEMI was an independent predictor of non-
ompliance with guidelines. Indeed, trials have shown that
atients with atypical STEMI do not receive appropriate
reatment because of difﬁculties in its diagnosis [16,17].
Time of symptom onset was also an independent predic-
or of compliance with guidelines, which were less likely
o be followed when patients presented during the night.
ne hypothesis is that these patients wait for longer before
elephoning for medical assistance and are therefore less
ikely to receive reperfusion therapy. In our study, manage-
ent strategies initiated by physicians were not dependent
n whether patients presented during the day or night. This
emarkable result is explained by the 24-hour availability of
edical care, including cardiac catheterization, in France.
Initial management, whether it was in the ER or in a
ICU, was an independent predictor of compliance with
uidelines, but this factor was dependent upon where
he patient was located. Practice variation in the use of
vidence-based treatments has been reported in a German
egistry in patients admitted to hospitals with or with-
ut a cardiology department [18]. In the present study,
utside Haute-Garonne, emergency physicians in the pre-
ospital setting were more likely to follow the guidelines
han other physicians, whereas this was not the case for
mergency physicians working in Haute-Garonne. The dif-
erence in compliance between the two regions suggests
hat physicians outside Haute-Garonne are following a prag-
atic strategy for choice of reperfusion therapy, because
atients in this area had very limited access to inter-
entional facilities. In the complementary ESTIM registry,
istance from a catheterization laboratory was measured
or prehospital management: 90% of patients living out-
ide Haute-Garonne were treated more than 80 km from
catheterization laboratory (unpublished data). In the
resent study, in most instances prehospital physicians
ased outside Haute-Garonne administered thrombolysis in
ccordance with guideline recommendations. In contrast,
n an area supported by many high-volume catheterization
I
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wS. Charpentier et al.
aboratories, prehospital physicians followed guidelines less
tringently and were more likely to offer alternative meth-
ds of initial management.
Compliance with guidelines was associated with short-
erm prognosis. Schiele et al. showed a relationship between
uidelines (including revascularization strategies and use of
ecommended drugs) and 1-year mortality [5]. In another
egistry, use of evidence-based therapy was associated
ith lower hospital mortality [18]. Thus, identifying factors
ssociated with non-compliance presents an opportunity in
hich to improve the management of patients who present
ith such factors.
Implementation of reperfusion therapy had an impor-
ant role in guidelines. Use of reperfusion was a very strong
rognosis factor in univariate analysis; patients who did not
eceive reperfusion therapy had a sevenfold higher mortality
han patients who received reperfusion therapy. However,
egistry studies report that even if use of reperfusion ther-
py increased, it is still implemented insufﬁciently [2]. New
uidelines proposed by the European Society of Cardiology
ublished in 2005 highlight the importance of early reper-
usion therapy in patients with acute myocardial infarction;
he main objective is to increase, to at least 75%, the pro-
ortion of patients who receive reperfusion therapy [2].
In our registry, other independent factors of mortality
ere age above 75 years, having a typical STEMI, and female
ex. The issue of elderly patients, difﬁculties associated with
heir management, and the beneﬁt of reperfusion therapy
re discussed above. The prognosis for patients present-
ng with a typical STEMI appears worse than for those with
typical clinical characteristics. For these patients, anterior
yocardial infarctions are the most critical, and are associ-
ted with a higher risk of cardiogenic shock and arrhythmias
han infarcts in other locations. For this reason, the progno-
is for patients presenting with a typical STEMI were worse
han for atypical STEMI despite the fact that guideline rec-
mmendations are more likely to be followed.
Women had a worse prognosis than men. Trials often show
hat women are less likely to be given reperfusion therapies
han men [19,20]. The main reasons identiﬁed in these stud-
es were that women often present with atypical symptoms
nd with more comorbid conditions than men [21]. Anderson
t al. also commented on the complexity of sex differences
n the treatment of acute myocardial infarction [22].
Finally, in the present study, location (Haute-Garonne vs
utside Haute-Garonne) was not associated with 1-month
ortality in patients with STEMI. These ﬁndings suggest that
he mortality rate in an area with very limited access car-
iac catheterization facilities is similar to that in an area
ith easy access to hospitals with high-volume catheteri-
ation laboratories. Prehospital ﬁbrinolysis decreases time
o reperfusion and improves outcomes, such as mortality, in
atients with STEMI. This decrease in time to reperfusion
ight be particularly beneﬁcial in areas in which primary
CI facilities are not immediately available.
tudy limitationst is impossible to determine the exact number of patients
ho had a myocardial infarction, particularly a STEMI, in
he Midi-Pyrénées region. As a consequence, some patients
ith STEMI, such as those who did not receive any form of
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reperfusion therapy, may have been missed. This limitation
may explain the low rate of patients who were not given
reperfusion therapy compared with other registry studies
[23]. However, the results from our registry were similar
to other French registries regarding time to initial medical
management and mortality [24,25].
Since the time to reach a PCI-capable hospital was not
collected in our registry, patients were separated according
to their management within or outside Haute-Garonne. The
distance from a catheterization laboratory was homoge-
neous in these two groups at the time of the study. Data
from another study found that as many as 90% of patients
living outside Haute-Garonne were treated more than 80 km
from a catheterization laboratory and were unable to have
a primary PCI within 90minutes (unpublished data).
We found that the strongest predictor of compliance was
location, which exhibited signiﬁcant interaction with type
of ﬁrst medical contact. These ﬁndings suggest that the
results found in this analysis might be speciﬁc to the health-
care system on which the data were collected and may not
be generalizable to other healthcare systems. The SAMU in
France has well trained prehospital management medical
teams with an efﬁcient centralized triage system that may
not be present in other healthcare systems.
Our registry did not include data regarding medical his-
tory or comorbid conditions that are prognostic factors in
STEMI. Thus the impact of guideline compliance on outcome
must be interpreted with caution. According to Schiele et
al., guideline compliance and cardiac risk or severity scores
are independent predictors of 1-year mortality [5]. How-
ever, interrelation between compliance and risk may exist
because comorbidities inﬂuence the use of reperfusion ther-
apy among eligible patients with STEMI. Parker et al. found
that pre-existing conditions exerted a large impact on the
non-use of reperfusion therapy [26]. Similarly, Alter et al.
found that higher cardiovascular risk and greater number
of comorbid condition were predictors of non-utilization of
reperfusion strategies in eligible patients [27].
Conclusions
Evidence-based recommendations for reperfusion therapy
were adequately implemented for two-thirds of patients
with acute myocardial infarction in the Midi-Pyrénées area
of France. However, there were some discrepancies depend-
ing on the type of initial medical management. Elderly
patients, those with atypical STEMI, and symptom onset dur-
ing the night were associated with failure to comply with
guidelines. First medical contact was a predictor of compli-
ance, but was dependent on the area in which the patient
was managed, that is, far from or close to a high-volume
catheterization laboratory.
Short-term prognosis was worse when patients were
managed without following guideline recommendations.
Identifying determinants of failure to comply with guidelines
is important to improve clinical management of patients
with STEMI, especially implementation of reperfusion ther-
apy. Real efforts shall be made to improve access to
reperfusion therapy. Expert committees from the European
Society of Cardiology suggest widespread dissemination of
these recommendations and development of training pro-
[uidelines 395
rammes, together with the launch of registry studies and
ngoing assessment to improve the outcomes for patients
ith acute myocardial infarction.
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